Akoya Biosciences (NASDAQ:AKYA) Receives Equal Weight Rating from Stephens
Akoya Biosciences (NASDAQ:AKYA – Get Free Report)‘s stock had its “equal weight” rating reiterated by equities researchers at Stephens in a note issued to investors on Tuesday,Benzinga reports. They currently have a $1.80 price objective on the stock, down from their previous price objective of $3.50. Stephens’ target price suggests a potential upside of 24.14% […]
More Stories
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...